0001209191-22-018669.txt : 20220314
0001209191-22-018669.hdr.sgml : 20220314
20220314200127
ACCESSION NUMBER: 0001209191-22-018669
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220314
DATE AS OF CHANGE: 20220314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lager Joanne Jenkins
CENTRAL INDEX KEY: 0001816215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 22738439
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET
STREET 2: BLDG 312, FLOOR 3, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-11
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816215
Lager Joanne Jenkins
321 ARSENAL STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Medical Officer
Common Stock
2022-03-11
4
M
0
3500
4.30
A
3500
D
Common Stock
2022-03-11
4
S
0
3500
36.01
D
0
D
Stock Option (Right to Buy)
36.21
2022-03-11
4
A
0
85000
0.00
A
2032-03-11
Common Stock
85000
85000
D
Stock Option (Right to Buy)
4.30
2022-03-11
4
M
0
3500
0.00
D
2025-06-11
Common Stock
3500
178938
D
This stock option shall vest over 4 years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer.
One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date
/s/ Adi Osovsky, as Attorney-in-Fact
2022-03-14